MDS Reports Overall Losses, But Improved Position for Proteomics, Instruments | GenomeWeb

NEW YORK, Dec. 12 (GenomeWeb News) - MDS Inc. reported a 19 percent increase for its Sciex analytical instruments business in year-over-year revenue for its fiscal year fourth quarter, which ended Oct. 31; and a decline in operating losses for MDS Proteomics.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.